Article info
1. From molecular pathways to clinical trials
Targeting therapeutics to arthritic joints by antibody specific to post-translationally modified collagen type II
Citation
Targeting therapeutics to arthritic joints by antibody specific to post-translationally modified collagen type II
Publication history
- First published February 22, 2012.
Online issue publication
March 09, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions